Healthcare provider profile · identity verified

David Grace, M.D.

Internal Medicine · PLYMOUTH, MA · NPI 1619043304

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	810	224
Amlodipine Besylate	Amlodipine Besylate	565	163
Levothyroxine Sodium	Levothyroxine Sodium	523	116
Losartan Potassium	Losartan Potassium	492	145
Lisinopril	Lisinopril	411	115
Metoprolol Succinate	Metoprolol Succinate	380	106
Pravastatin Sodium	Pravastatin Sodium	346	102
Omeprazole	Omeprazole	344	110
Simvastatin	Simvastatin	260	68
Rosuvastatin Calcium	Rosuvastatin Calcium	254	80
Tamsulosin Hcl	Tamsulosin Hcl	217	71
Hydrochlorothiazide	Hydrochlorothiazide	216	63
Metformin Hcl Er	Metformin Hcl	198	61
Escitalopram Oxalate	Escitalopram Oxalate	196	54
Pantoprazole Sodium	Pantoprazole Sodium	192	54
Gabapentin	Gabapentin	180	47
Trazodone Hcl	Trazodone Hcl	173	57
Atenolol	Atenolol	166	48
Potassium Chloride	Potassium Chloride	164	32
Eliquis	Apixaban	163	37
Famotidine	Famotidine	158	42
Metoprolol Tartrate	Metoprolol Tartrate	151	42
Jardiance	Empagliflozin	144	35
Lorazepam	Lorazepam	137	29
Metformin Hcl	Metformin Hcl	132	33
Allopurinol	Allopurinol	111	32
Finasteride	Finasteride	109	26
Furosemide	Furosemide	104	43
Warfarin Sodium	Warfarin Sodium	101	25
Alendronate Sodium	Alendronate Sodium	98	28
Albuterol Sulfate Hfa	Albuterol Sulfate	91	41
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	90	89
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	85	85
Sertraline Hcl	Sertraline Hcl	83	28
Fluticasone Propionate	Fluticasone Propionate	81	39
Ezetimibe	Ezetimibe	80	21
Buspirone Hcl	Buspirone Hcl	78	21
Donepezil Hcl	Donepezil Hcl	73	21
Citalopram Hbr	Citalopram Hydrobromide	71	17
Clopidogrel	Clopidogrel Bisulfate	67	23
Clonazepam	Clonazepam	64	suppressed
Tramadol Hcl	Tramadol Hcl	63	18
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	62	19
Spironolactone	Spironolactone	61	22
Pregabalin	Pregabalin	60	suppressed
Glimepiride	Glimepiride	59	16
Shingrix	Varicella-Zoster Ge/As01b/Pf	59	49
Azelastine Hcl	Azelastine Hcl	53	19
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	53	14
Tizanidine Hcl	Tizanidine Hcl	51	20
Paroxetine Hcl	Paroxetine Hcl	50	13
Breo Ellipta	Fluticasone/Vilanterol	46	11
Duloxetine Hcl	Duloxetine Hcl	46	15
Doxazosin Mesylate	Doxazosin Mesylate	45	12
Nifedipine Er	Nifedipine	45	12
Trulicity	Dulaglutide	45	suppressed
Synthroid	Levothyroxine Sodium	44	12
Zolpidem Tartrate	Zolpidem Tartrate	44	17
Hydralazine Hcl	Hydralazine Hcl	40	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	39	suppressed
Labetalol Hcl	Labetalol Hcl	39	13
Celecoxib	Celecoxib	38	15
Fluoxetine Hcl	Fluoxetine Hcl	38	suppressed
Meloxicam	Meloxicam	38	suppressed
Xarelto	Rivaroxaban	38	suppressed
Carvedilol	Carvedilol	37	11
Mirtazapine	Mirtazapine	37	suppressed
Ozempic	Semaglutide	36	suppressed
Ibuprofen	Ibuprofen	35	14
Triamcinolone Acetonide	Triamcinolone Acetonide	35	21
Arnuity Ellipta	Fluticasone Furoate	33	suppressed
Diclofenac Sodium	Diclofenac Sodium	32	12
Ipratropium Bromide	Ipratropium Bromide	32	suppressed
Prednisone	Prednisone	32	21
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	31	suppressed
Lovastatin	Lovastatin	31	suppressed
Memantine Hcl	Memantine Hcl	31	suppressed
Estradiol	Estradiol	30	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	30	suppressed
Alprazolam	Alprazolam	29	12
Montelukast Sodium	Montelukast Sodium	29	11
Nitroglycerin	Nitroglycerin	29	19
Valacyclovir	Valacyclovir Hcl	29	14
Glipizide	Glipizide	28	suppressed
Valsartan	Valsartan	28	12
Incruse Ellipta	Umeclidinium Bromide	27	suppressed
Propranolol Hcl	Propranolol Hcl	27	suppressed
Morphine Sulfate Er	Morphine Sulfate	26	suppressed
Ropinirole Hcl	Ropinirole Hcl	26	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	25	suppressed
Amiodarone Hcl	Amiodarone Hcl	22	suppressed
Ketoconazole	Ketoconazole	22	14
Klor-Con M20	Potassium Chloride	22	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	22	suppressed
Symbicort	Budesonide/Formoterol Fumarate	22	suppressed
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Irbesartan	Irbesartan	20	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	20	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	20	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	19	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	19	16
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	19	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	19	suppressed
Baclofen	Baclofen	18	suppressed
Diazepam	Diazepam	18	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	18	suppressed
Amoxicillin	Amoxicillin	17	suppressed
Lamotrigine	Lamotrigine	17	suppressed
Levoxyl	Levothyroxine Sodium	17	suppressed
Oxycodone Hcl	Oxycodone Hcl	17	suppressed
Torsemide	Torsemide	17	suppressed
Cilostazol	Cilostazol	16	suppressed
Divalproex Sodium	Divalproex Sodium	16	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	16	suppressed
Colchicine	Colchicine	15	suppressed
Lansoprazole	Lansoprazole	15	suppressed
Sildenafil Citrate	Sildenafil Citrate	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	11
Wixela Inhub	Fluticasone Propion/Salmeterol	15	suppressed
Budesonide	Budesonide	14	suppressed
Calcitriol	Calcitriol	14	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Loperamide	Loperamide Hcl	14	suppressed
Mounjaro	Tirzepatide	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	12
Ventolin Hfa	Albuterol Sulfate	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	12
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Nitroglycerin Patch	Nitroglycerin	13	suppressed
Albuterol Sulfate	Albuterol Sulfate	12	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	12	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Clotrimazole	Clotrimazole	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Naproxen	Naproxen	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Divalproex Sodium Er	Divalproex Sodium	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Lactulose	Lactulose	11	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	11	suppressed
Primidone	Primidone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error